JP2024516713A5 - - Google Patents
Info
- Publication number
- JP2024516713A5 JP2024516713A5 JP2023568216A JP2023568216A JP2024516713A5 JP 2024516713 A5 JP2024516713 A5 JP 2024516713A5 JP 2023568216 A JP2023568216 A JP 2023568216A JP 2023568216 A JP2023568216 A JP 2023568216A JP 2024516713 A5 JP2024516713 A5 JP 2024516713A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cdr
- seq
- chain complementarity
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185896P | 2021-05-07 | 2021-05-07 | |
| US63/185,896 | 2021-05-07 | ||
| US202163283147P | 2021-11-24 | 2021-11-24 | |
| US63/283,147 | 2021-11-24 | ||
| PCT/US2022/028202 WO2022236142A2 (en) | 2021-05-07 | 2022-05-06 | Chimeric receptors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516713A JP2024516713A (ja) | 2024-04-16 |
| JP2024516713A5 true JP2024516713A5 (https=) | 2025-05-14 |
Family
ID=83933024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568216A Pending JP2024516713A (ja) | 2021-05-07 | 2022-05-06 | キメラ受容体およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240173410A1 (https=) |
| EP (1) | EP4334346A4 (https=) |
| JP (1) | JP2024516713A (https=) |
| KR (1) | KR20240004680A (https=) |
| AU (1) | AU2022270717A1 (https=) |
| CA (1) | CA3217614A1 (https=) |
| IL (1) | IL308148A (https=) |
| TW (1) | TW202309091A (https=) |
| WO (1) | WO2022236142A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020092839A1 (en) | 2018-10-31 | 2020-05-07 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| EP3873540A4 (en) | 2018-10-31 | 2022-07-27 | Mayo Foundation for Medical Education and Research | METHODS AND MATERIALS FOR THE TREATMENT OF CANCER |
| TW202506715A (zh) * | 2023-04-17 | 2025-02-16 | 美商聖堤生物科技股份有限公司 | 抗原結合域及其使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3202419A1 (en) * | 2012-06-06 | 2017-08-09 | OncoMed Pharmaceuticals, Inc. | Pvrig binding agents that modulate the hippo pathway and uses thereof |
| WO2019024979A1 (en) * | 2017-07-31 | 2019-02-07 | Institute For Research In Biomedicine | FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION |
| US20220177583A1 (en) * | 2019-03-20 | 2022-06-09 | The Regents Of The University Of California | Claudin-6 bispecific antibodies |
| TW202110873A (zh) * | 2019-04-30 | 2021-03-16 | 美商聖堤生物科技股份有限公司 | 嵌合受體及其使用方法 |
| CN111378037B (zh) * | 2020-06-01 | 2020-09-01 | 南京诺艾新生物技术有限公司 | 一种抗hIL-33人源化单抗及其应用 |
-
2022
- 2022-05-06 AU AU2022270717A patent/AU2022270717A1/en active Pending
- 2022-05-06 CA CA3217614A patent/CA3217614A1/en active Pending
- 2022-05-06 WO PCT/US2022/028202 patent/WO2022236142A2/en not_active Ceased
- 2022-05-06 KR KR1020237040933A patent/KR20240004680A/ko active Pending
- 2022-05-06 JP JP2023568216A patent/JP2024516713A/ja active Pending
- 2022-05-06 EP EP22799728.5A patent/EP4334346A4/en active Pending
- 2022-05-06 TW TW111117214A patent/TW202309091A/zh unknown
- 2022-05-06 IL IL308148A patent/IL308148A/en unknown
-
2023
- 2023-11-07 US US18/504,037 patent/US20240173410A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102777002B1 (ko) | 항글리피칸-3 항체 및 이의 응용 | |
| EP3738609B1 (en) | Antigen binding molecules comprising a tnf family ligand trimer | |
| JP2024516713A5 (https=) | ||
| JP2018533371A5 (https=) | ||
| WO2020060406A1 (en) | Novel bispecific antibodies for use in the treatment of hematological malignancies | |
| KR20190034588A (ko) | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 | |
| IL268206B1 (en) | Bcma-targeting antibody and use thereof | |
| CN111727057A (zh) | 与lag3和pd1结合的治疗分子 | |
| JP2022542559A5 (https=) | ||
| JP2024504820A (ja) | 抗ｔｎｆｒ２ヒト化抗体及びその使用 | |
| JP7646768B2 (ja) | 抗－ヒトプログラム細胞死リガンド－１（ｐｄ－ｌ１）の抗体及びその用途 | |
| CN111848809A (zh) | 靶向Claudin18.2的CAR分子、其修饰的免疫细胞及用途 | |
| JP2024138555A (ja) | 抗体製剤 | |
| JP2023530083A (ja) | Ｈｌａ－ｇ及び別の抗原に対して結合特異性を有する二重特異性免疫細胞エンゲージャー | |
| JP2023549555A5 (https=) | ||
| JP2019537449A5 (https=) | ||
| JP2023545517A5 (https=) | ||
| US20240180968A1 (en) | Adgre2 chimeric receptor nk cell compositions and methods of use | |
| IL302148A (en) | Chimeric receptors and methods of use thereof | |
| CN118696062A (zh) | 人源化抗cd28抗体及其与抗cd40的双特异性抗体 | |
| TW202317640A (zh) | 一種抗人pd-l1人源化抗體或其抗原結合片段及其應用 | |
| JP7725066B2 (ja) | ヒト化抗ｐｄ－ｌ１抗体 | |
| WO2024193669A1 (zh) | 抗tnfr2/抗pd-1或ctla-4双特异性抗体及其应用 | |
| KR20230162597A (ko) | 안정적인 다중 특이성 분자 및 그 이용 | |
| JP2022552786A5 (https=) |